1. CNRS Toulouse, France
2. Université Paul Sabatier, France
3. Waseda University, Japan
4. Monash University Malaysia, Malaysia

Abstract

The Neuropeptide FF receptor family contains two subtypes, NPFF1 and NPFF2 (provisional nomenclature [12]), which exhibit high affinities for neuropeptide FF (NPFF, O15130) and RFamide related peptides (RFRP: precursor gene symbol NPVF, Q9HCQ7). NPFF1 is broadly distributed in the central nervous system with the highest levels found in the limbic system and the hypothalamus. NPFF2 is present in high density in the superficial layers of the mammalian spinal cord where it is involved in nociception and modulation of opioid functions.

Contents

GtoPdb is an expert-driven guide to pharmacological targets and the substances that act on them. GtoPdb is a reference work which is most usefully represented as an on-line database. As in any publication this work should be appropriately cited, and the papers it cites should also be recognized. This document provides a citation for the relevant parts of the database, and also provides a reference list for the research cited by those parts. For further details see [4].

Please note that the database version for the citations given in GtoPdb are to the most recent preceding version in which the family or its subfamilies and targets were substantially changed. The links below are to the current version. If you need to consult the cited version, rather than the most recent version, please contact the GtoPdb curators.

Database links

References

1. Allard M, Labrouche S, Nosjean A and Laguzzi R. (1995) Mechanisms underlying the cardiovascular responses to peripheral administration of NPFF in the rat. J Pharmacol Exp Ther 274: 577-83 [PMID:7616447]
2. Ballet S, Mauborgne A, Gouardères C, Bourgoin AS, Zajac JM, Hamon M and Cesselin F. (1999) The neuropeptide FF analogue, 1DME, enhances in vivo met-enkephalin release from the rat spinal cord. Neuropharmacology 38: 1317-24 [PMID:10471085]
3. Bonini JA, Jones KA, Adham N, Forray C, Artymyshyn R, Durkin MM, Smith KE, Tamm JA, Boteju LW and Lakhlani PP et al.. (2000) Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J Biol Chem 275: 39324-31 [PMID:11024015]
4. Buneman P, Christie G, Davies JA, Dimitrellou R, Harding SD, Pawson AJ, Sharman JL and Wu Y. (2020) Why data citation isn't working, and what to do about it Database 2020 [PMID:32367113]
5. Clarke IJ, Sari IP, Qi Y, Smith JT, Parkington HC, Ubuka T, Iqbal J, Li Q, Tilbrook A and Morgan K et al.. (2008) Potent action of RFamide-related peptide-3 on pituitary gonadotropes indicative of a hypophysiotropic role in the negative regulation of gonadotropin secretion. Endocrinology 149: 5811-21 [PMID:18617613]
6. Davidson JS, Assefa D, Pawson A, Davies P, Hapgood J, Becker I, Flanagan C, Roeske R and Millar R. (1997) Irreversible activation of the gonadotropin-releasing hormone receptor by photoaffinity cross-linking: localization of attachment site to Cys residue in N-terminal segment. Biochemistry 36: 12881-9 [PMID:9335546]
7. Desprat C and Zajac JM. (1997) Hypothermic effects of neuropeptide FF analogues in mice. Pharmacol Biochem Behav 58: 559-63 [PMID:9300619]
8. Dockray GJ. (2004) The expanding family of -RFamide peptides and their effects on feeding behaviour. Exp Physiol 89: 229-35 [PMID:15123557]
9. Ducret E, Anderson GM and Herbison AE. (2009) RFamide-related peptide-3, a mammalian gonadotropin-inhibitory hormone ortholog, regulates gonadotropin-releasing hormone neuron firing in the mouse. Endocrinology 150: 2799-804 [PMID:19131572]
10. Elhabazi K, Trigo JM, Mollereau C, Moulédous L, Zajac JM, Bihel F, Schmitt M, Bourguignon JJ, Meziane H and Petit-demoulière B et al.. (2012) Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments. Br J Pharmacol 165: 424-35 [PMID:21718302]
11. Elshourbagy NA, Ames RS, Fitzgerald LR, Foley JJ, Chambers JK, Szekeres PG, Evans NA, Schmidt DB, Buckley PT and Dytko GM et al.. (2000) Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor. J Biol Chem 275: 25965-71 [PMID:10851242]
12. Foord SM, Bonner TI, Neubig RR, Rosser EM, Pin JP, Davenport AP, Spedding M and Harmar AJ. (2005) International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev 57: 279-88 [PMID:15914470]
13. Fukusumi S, Habata Y, Yoshida H, Iijima N, Kawamata Y, Hosoya M, Fujii R, Hinuma S, Kitada C and Shintani Y et al.. (2001) Characteristics and distribution of endogenous RFamide-related peptide-1. Biochim Biophys Acta 1540: 221-32 [PMID:11583817]
14. Goncharuk V, Zeng Z, Wang R, MacTavish D and Jhamandas JH. (2004) Distribution of the neuropeptide FF1 receptor (hFF1) in the human hypothalamus and surrounding basal forebrain structures: immunohistochemical study. J Comp Neurol 474: 487-503 [PMID:15174068]
15. Gouardères C, Mazarguil H, Mollereau C, Chartrel N, Leprince J, Vaudry H and Zajac JM. (2007) Functional differences between NPFF1 and NPFF2 receptor coupling: high intrinsic activities of RFamide-related peptides on stimulation of [35S]GTPgammaS binding. Neuropharmacology 52: 376-86 [PMID:17011599]
16. Gouardères C, Mollereau C, Tafani JA, Mazarguil H and Zajac JM. (2001) [(125)I]EYF: a new high affinity radioligand to neuropeptide FF receptors. Peptides 22: 623-9 [PMID:11311733]
17. Gouardères C, Puget A and Zajac JM. (2004) Detailed distribution of neuropeptide FF receptors (NPFF1 and NPFF2) in the rat, mouse, octodon, rabbit, guinea pig, and marmoset monkey brains: a comparative autoradiographic study. Synapse 51: 249-69 [PMID:14696013]
18. Gouardères C, Quelven I, Mollereau C, Mazarguil H, Rice SQ and Zajac JM. (2002) Quantitative autoradiographic distribution of NPFF1 neuropeptide FF receptor in the rat brain and comparison with NPFF2 receptor by using [125I]YVP and [(125I]EYF as selective radioligands. Neuroscience 115: 349-61 [PMID:12421602]
19. Gouardères C, Sutak M, Zajac JM and Jhamandas K. (1993) Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Eur J Pharmacol 237: 73-81 [PMID:8102975]
20. Gouardères C and Zajac JM. (2007) Biochemical anti-opioid action of NPFF2 receptors in rat spinal cord. Neurosci Res 58: 91-4 [PMID:17337079]
21. Hinuma S, Shintani Y, Fukusumi S, Iijima N, Matsumoto Y, Hosoya M, Fujii R, Watanabe T, Kikuchi K and Terao Y et al.. (2000) New neuropeptides containing carboxy-terminal RFamide and their receptor in mammals. Nat Cell Biol 2: 703-8 [PMID:11025660]
22. Jhamandas JH, MacTavish D and Harris KH. (2006) Neuropeptide FF (NPFF) control of magnocellular neurosecretory cells of the rat hypothalamic paraventricular nucleus (PVN). Peptides 27: 973-9 [PMID:16517015]
23. Jhamandas JH, Simonin F, Bourguignon JJ and Harris KH. (2007) Neuropeptide FF and neuropeptide VF inhibit GABAergic neurotransmission in parvocellular neurons of the rat hypothalamic paraventricular nucleus. Am J Physiol Regul Integr Comp Physiol 292: R1872-80 [PMID:17289819]
24. Johnson MA, Tsutsui K and Fraley GS. (2007) Rat RFamide-related peptide-3 stimulates GH secretion, inhibits LH secretion, and has variable effects on sex behavior in the adult male rat. Horm Behav 51: 171-80 [PMID:17113584]
25. Journigan VB, Mésangeau C, Vyas N, Eans SO, Cutler SJ, McLaughlin JP, Mollereau C and McCurdy CR. (2014) Nonpeptide small molecule agonist and antagonist original leads for neuropeptide FF1 and FF2 receptors. J Med Chem 57: 8903-27 [PMID:25268943]
26. Kadokawa H, Shibata M, Tanaka Y, Kojima T, Matsumoto K, Oshima K and Yamamoto N. (2009) Bovine C-terminal octapeptide of RFamide-related peptide-3 suppresses luteinizing hormone (LH) secretion from the pituitary as well as pulsatile LH secretion in bovines. Domest Anim Endocrinol 36: 219-24 [PMID:19328642]
27. Kaewwongse M, Takayanagi Y and Onaka T. (2011) Effects of RFamide-related peptide (RFRP)-1 and RFRP-3 on oxytocin release and anxiety-related behaviour in rats. J Neuroendocrinol 23: 20-7 [PMID:21029217]
28. Kersanté F, Mollereau C, Zajac JM and Roumy M. (2006) Anti-opioid activities of NPFF1 receptors in a SH-SY5Y model. Peptides 27: 980-9 [PMID:16488058]
29. Kersanté F, Wang JY, Chen JC, Mollereau C and Zajac JM. (2011) Anti-opioid effects of neuropeptide FF receptors in the ventral tegmental area. Neurosci Lett 488: 305-9 [PMID:21111027]
30. Kirby ED, Geraghty AC, Ubuka T, Bentley GE and Kaufer D. (2009) Stress increases putative gonadotropin inhibitory hormone and decreases luteinizing hormone in male rats. Proc Natl Acad Sci USA 106: 11324-9 [PMID:19541621]
31. Kotani M, Mollereau C, Detheux M, Le Poul E, Brézillon S, Vakili J, Mazarguil H, Vassart G, Zajac JM and Parmentier M. (2001) Functional characterization of a human receptor for neuropeptide FF and related peptides. Br J Pharmacol 133: 138-44 [PMID:11325803]
32. Kriegsfeld LJ, Mei DF, Bentley GE, Ubuka T, Mason AO, Inoue K, Ukena K, Tsutsui K and Silver R. (2006) Identification and characterization of a gonadotropin-inhibitory system in the brains of mammals. Proc Natl Acad Sci USA 103: 2410-5 [PMID:16467147]
33. Lameh J, Bertozzi F, Kelly N, Jacobi PM, Nguyen D, Bajpai A, Gaubert G, Olsson R and Gardell LR. (2010) Neuropeptide FF receptors have opposing modulatory effects on nociception. J Pharmacol Exp Ther 334: 244-54 [PMID:20354177]
34. Lefrere I, De Coppet P, Camelin JC, Le Lay S, Mercier N, Elshourbagy N, Bril A, Berrebi-Bertrand I, Feve B and Krief S. (2002) Neuropeptide AF and FF modulation of adipocyte metabolism. Primary insights from functional genomics and effects on beta-adrenergic responsiveness. J Biol Chem 277: 39169-78 [PMID:12149260]
35. Liu Q, Guan XM, Martin WJ, McDonald TP, Clements MK, Jiang Q, Zeng Z, Jacobson M, Williams Jr DL and Yu H et al.. (2001) Identification and characterization of novel mammalian neuropeptide FF-like peptides that attenuate morphine-induced antinociception. J Biol Chem 276: 36961-9 [PMID:11481330]
36. Marchand S, Betourne A, Marty V, Daumas S, Halley H, Lassalle JM, Zajac JM and Frances B. (2006) A neuropeptide FF agonist blocks the acquisition of conditioned place preference to morphine in C57Bl/6J mice. Peptides 27: 964-72 [PMID:16494968]
37. Marco N, Stinus L, Allard M, Le Moal M and Simonnet G. (1995) Neuropeptide FLFQRFamide receptors within the ventral mesenchephalon and dopaminergic terminal areas: localization and functional antiopioid involvement. Neuroscience 64: 1035-44 [PMID:7753374]
38. Mollereau C, Gouardères C, Dumont Y, Kotani M, Detheux M, Doods H, Parmentier M, Quirion R and Zajac JM. (2001) Agonist and antagonist activities on human NPFF(2) receptors of the NPY ligands GR231118 and BIBP3226. Br J Pharmacol 133: 1-4 [PMID:11325787]
39. Mollereau C, Mazarguil H, Marcus D, Quelven I, Kotani M, Lannoy V, Dumont Y, Quirion R, Detheux M and Parmentier M et al.. (2002) Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists. Eur J Pharmacol 451: 245-56 [PMID:12242085]
40. Mollereau C, Mazarguil H, Zajac JM and Roumy M. (2005) Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells. Mol Pharmacol 67: 965-75 [PMID:15608144]
41. Mollereau C, Roumy M and Zajac JM. (2005) Opioid-modulating peptides: mechanisms of action. Curr Top Med Chem 5: 341-355 [PMID:15857316]
42. Moulédous L, Frances B and Zajac JM. (2010) Modulation of basal and morphine-induced neuronal activity by a NPFF(2) selective agonist measured by c-Fos mapping of the mouse brain. Synapse 64: 672-81 [PMID:20336629]
43. Moulédous L, Froment C, Dauvillier S, Burlet-Schiltz O, Zajac JM and Mollereau C. (2012) GRK2 protein-mediated transphosphorylation contributes to loss of function of μ-opioid receptors induced by neuropeptide FF (NPFF2) receptors. J Biol Chem 287: 12736-49 [PMID:22375000]
44. Moulédous L, Mollereau C and Zajac JM. (2010) Opioid-modulating properties of the neuropeptide FF system. Biofactors 36: 423-9 [PMID:20803521]
45. Murakami M, Matsuzaki T, Iwasa T, Yasui T, Irahara M, Osugi T and Tsutsui K. (2008) Hypophysiotropic role of RFamide-related peptide-3 in the inhibition of LH secretion in female rats. J Endocrinol 199: 105-12 [PMID:18653621]
46. Murase T, Arima H, Kondo K and Oiso Y. (1996) Neuropeptide FF reduces food intake in rats. Peptides 17: 353-4 [PMID:8801545]
47. Panula P, Kalso E, Nieminen M, Kontinen VK, Brandt A and Pertovaara A. (1999) Neuropeptide FF and modulation of pain. Brain Res 848: 191-6 [PMID:10612711]
48. Perry SJ, Yi-Kung Huang E, Cronk D, Bagust J, Sharma R, Walker RJ, Wilson S and Burke JF. (1997) A human gene encoding morphine modulating peptides related to NPFF and FMRFamide. FEBS Lett 409: 426-30 [PMID:9224703]
49. Pineda R, Garcia-Galiano D, Sanchez-Garrido MA, Romero M, Ruiz-Pino F, Aguilar E, Dijcks FA, Blomenröhr M, Pinilla L and van Noort PI et al.. (2010) Characterization of the potent gonadotropin-releasing activity of RF9, a selective antagonist of RF-amide-related peptides and neuropeptide FF receptors: physiological and pharmacological implications. Endocrinology 151: 1902-13 [PMID:20160130]
50. Quelven I, Roussin A and Zajac JM. (2005) Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists. Eur J Pharmacol 508: 107-14 [PMID:15680260]
51. Rebeyrolles S, Zajac JM and Roumy M. (1996) Neuropeptide FF reverses the effect of mu-opioid on Ca2+ channels in rat spinal ganglion neurones. Neuroreport 7: 2979-81 [PMID:9116223]
52. Roth BL, Disimone J, Majane EA and Yang HY. (1987) Elevation of arterial pressure in rats by two new vertebrate peptides FLFQPQRF-NH2 and AGEGLSSPFWSLAAPQRF-NH2 which are immunoreactive to FMRF-NH2 antiserum. Neuropeptides 10: 37-42 [PMID:3670567]
53. Roumy M, Garnier M and Zajac JM. (2003) Neuropeptide FF receptors 1 and 2 exert an anti-opioid activity in acutely dissociated rat dorsal raphe and periventricular hypothalamic neurones. Neurosci Lett 348: 159-62 [PMID:12932818]
54. Roumy M, Lorenzo C, Mazères S, Bouchet S, Zajac JM and Mollereau C. (2007) Physical association between neuropeptide FF and micro-opioid receptors as a possible molecular basis for anti-opioid activity. J Biol Chem 282: 8332-42 [PMID:17224450]
55. Roumy M and Zajac J. (1999) Neuropeptide FF selectively attenuates the effects of nociceptin on acutely dissociated neurons of the rat dorsal raphe nucleus. Brain Res 845: 208-14 [PMID:10536200]
56. Roumy M and Zajac JM. (1998) Neuropeptide FF, pain and analgesia. Eur J Pharmacol 345: 1-11 [PMID:9593588]
57. Roussin A, Serre F, Gouardères C, Mazarguil H, Roumy M, Mollereau C and Zajac JM. (2005) Anti-analgesia of a selective NPFF2 agonist depends on opioid activity. Biochem Biophys Res Commun 336: 197-203 [PMID:16129413]
58. Sari IP, Rao A, Smith JT, Tilbrook AJ and Clarke IJ. (2009) Effect of RF-amide-related peptide-3 on luteinizing hormone and follicle-stimulating hormone synthesis and secretion in ovine pituitary gonadotropes. Endocrinology 150: 5549-56 [PMID:19808777]
59. Simonin F, Schmitt M, Laulin JP, Laboureyras E, Jhamandas JH, MacTavish D, Matifas A, Mollereau C, Laurent P and Parmentier M et al.. (2006) RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia. Proc Natl Acad Sci USA 103: 466-71 [PMID:16407169]
60. Smith JT, Young IR, Veldhuis JD and Clarke IJ. (2012) Gonadotropin-inhibitory hormone (GnIH) secretion into the ovine hypophyseal portal system. Endocrinology 153: 3368-75 [PMID:22549225]
61. Son YL, Ubuka T, Millar RP, Kanasaki H and Tsutsui K. (2012) Gonadotropin-inhibitory hormone inhibits GnRH-induced gonadotropin subunit gene transcriptions by inhibiting AC/cAMP/PKA-dependent ERK pathway in LβT2 cells. Endocrinology 153: 2332-43 [PMID:22374973]
62. Son YL, Ubuka T, Narihiro M, Fukuda Y, Hasunuma I, Yamamoto K, Belsham DD and Tsutsui K. (2014) Molecular basis for the activation of gonadotropin-inhibitory hormone gene transcription by corticosterone. Endocrinology 155: 1817-26 [PMID:24552400]
63. Sunter D, Hewson AK, Lynam S and Dickson SL. (2001) Intracerebroventricular injection of neuropeptide FF, an opioid modulating neuropeptide, acutely reduces food intake and stimulates water intake in the rat. Neurosci Lett 313: 145-8 [PMID:11682148]
64. Takeuchi T, Fujita A, Roumy M, Zajac JM and Hata F. (2001) Effect of 1DMe, a neuropeptide FF analog, on acetylcholine release from myenteric plexus of guinea pig ileum. Jpn J Pharmacol 86: 417-22 [PMID:11569615]
65. Talmont F, Garcia LP, Mazarguil H, Zajac JM and Mollereau C. (2009) Characterization of two novel tritiated radioligands for labelling Neuropeptide FF (NPFF(1) and NPFF(2)) receptors. Neurochem Int 55: 815-9 [PMID:19682524]
66. Tsutsui K, Bentley GE, Bedecarrats G, Osugi T, Ubuka T and Kriegsfeld LJ. (2010) Gonadotropin-inhibitory hormone (GnIH) and its control of central and peripheral reproductive function. Front Neuroendocrinol 31: 284-95 [PMID:20211640]
67. Ubuka T, Inoue K, Fukuda Y, Mizuno T, Ukena K, Kriegsfeld LJ and Tsutsui K. (2012) Identification, expression, and physiological functions of Siberian hamster gonadotropin-inhibitory hormone. Endocrinology 153: 373-85 [PMID:22045661]
68. Ubuka T, Lai H, Kitani M, Suzuuchi A, Pham V, Cadigan PA, Wang A, Chowdhury VS, Tsutsui K and Bentley GE. (2009) Gonadotropin-inhibitory hormone identification, cDNA cloning, and distribution in rhesus macaque brain. J Comp Neurol 517: 841-55 [PMID:19844991]
69. Ubuka T, Morgan K, Pawson AJ, Osugi T, Chowdhury VS, Minakata H, Tsutsui K, Millar RP and Bentley GE. (2009) Identification of human GnIH homologs, RFRP-1 and RFRP-3, and the cognate receptor, GPR147 in the human hypothalamic pituitary axis. PLoS ONE 4: e8400 [PMID:20027225]
70. Ukena K, Iwakoshi E, Minakata H and Tsutsui K. (2002) A novel rat hypothalamic RFamide-related peptide identified by immunoaffinity chromatography and mass spectrometry. FEBS Lett 512: 255-8 [PMID:11852091]
71. Vilim FS, Aarnisalo AA, Nieminen ML, Lintunen M, Karlstedt K, Kontinen VK, Kalso E, States B, Panula P and Ziff E. (1999) Gene for pain modulatory neuropeptide NPFF: induction in spinal cord by noxious stimuli. Mol Pharmacol 55: 804-11 [PMID:10220558]
72. Wu M, Dumalska I, Morozova E, van den Pol AN and Alreja M. (2009) Gonadotropin inhibitory hormone inhibits basal forebrain vGluT2-gonadotropin-releasing hormone neurons via a direct postsynaptic mechanism. J Physiol (Lond.) 587: 1401-11 [PMID:19204051]
73. Yang HY, Fratta W, Majane EA and Costa E. (1985) Isolation, sequencing, synthesis, and pharmacological characterization of two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci USA 82: 7757-61 [PMID:3865193]
74. Yang HY and Iadarola MJ. (2006) Modulatory roles of the NPFF system in pain mechanisms at the spinal level. Peptides 27: 943-52 [PMID:16443306]
75. Yoshida H, Habata Y, Hosoya M, Kawamata Y, Kitada C and Hinuma S. (2003) Molecular properties of endogenous RFamide-related peptide-3 and its interaction with receptors. Biochim Biophys Acta 1593: 151-7 [PMID:12581859]
76. Zajac JM. (2001) Neuropeptide FF: new molecular insights. Trends Pharmacol Sci 22: 63 [PMID:11421201]